Could a tiny dose of radiation tame skin cancer lesions?
NCT ID NCT03398161
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase II trial tests whether ultra low dose radiation can control skin lesions in people with mycosis fungoides, a type of lymphoma. About 50 participants will receive very low doses of radiation to their skin lesions. The goal is to see if this gentler approach works as well as standard radiation but with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ultra low dose radiation therapy
- What this could lead to
- If successful, this could offer a gentler radiation option that controls skin lesions in mycosis fungoides with fewer side effects.
- What could go wrong
- This is a small, early-phase trial (50 people) testing a lower radiation dose, so it may not work as well as standard doses or may still cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED SKIN LESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Skin gel targets immune signals in rare lymphoma
- Could an ALS drug clear the fog of chemo brain?
- Combination therapy aims to boost response in rare skin cancers
- Supercharged immune cells aim to stop lymphoma comeback
- Massive T-Cell lymphoma database aims to unlock new insights
- Promising skin cancer trial pulled before it even started